DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PHOSPHORYLETHANOLAMINE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
PHOSPHORYLETHANOLAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
78A2BX7AEU
Molecule Type:
Small molecule
Molecular Formula:
C2H8NO4P
Molecular Weight:
141.06
AlogP:
-0.95
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
3.0
Source:
CAVOSONSTAT
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive
Alcohol dehydrogenase class III inhibitor
CAVOSONSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
O2Z8Q22ZE4
Molecule Type:
Small molecule
Molecular Formula:
C16H10ClNO3
Molecular Weight:
299.71
AlogP:
3.96
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
FISETIN
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee; Neoplasms; Severe Acute Respiratory Syndrome
Unknown
FISETIN
×
Maximum Phase:
2
First Approval:
None
UNII:
OO2ABO9578
Molecule Type:
Small molecule
Molecular Formula:
C15H10O6
Molecular Weight:
286.24
AlogP:
2.28
PSA:
111.13
HBD:
4.0
HBA:
#RotB:
1.0
Source:
ENMD-981693
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Pancreatic Neoplasms
Fibroblast growth factor receptor inhibitor
ENMD-981693
×
Maximum Phase:
2
First Approval:
None
UNII:
DNZ11VPY7Q
Molecule Type:
Small molecule
Molecular Formula:
C22H16N4O4
Molecular Weight:
400.39
AlogP:
3.15
PSA:
99.17
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LY2940094
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Alcoholism; Depressive Disorder, Major
Nociceptin receptor antagonist
LY2940094
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-275183
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Tubulin stabiliser
BMS-275183
×
Maximum Phase:
2
First Approval:
None
UNII:
UQC681JJIV
Molecule Type:
Small molecule
Molecular Formula:
C43H59NO16
Molecular Weight:
845.94
AlogP:
3.72
PSA:
239.75
HBD:
4.0
HBA:
#RotB:
8.0
Source:
MODOTUXIMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MODOTUXIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
1W7BD1M08N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
131I-RITUXIMAB
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
131I-RITUXIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK163090
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Depressive Disorder
Serotonin 1a (5-HT1a) receptor antagonist
GSK163090
×
Maximum Phase:
2
First Approval:
None
UNII:
7XI927X82B
Molecule Type:
Small molecule
Molecular Formula:
C25H29N5O
Molecular Weight:
415.54
AlogP:
3.44
PSA:
51.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IOWH-032
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases
Unknown
IOWH-032
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y3GDT6YWV
Molecule Type:
Small molecule
Molecular Formula:
C22H15Br2N3O4
Molecular Weight:
545.19
AlogP:
5.69
PSA:
97.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VOTUCALIS
2
Protein
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal; Inflammation
Unknown
VOTUCALIS
×
Maximum Phase:
2
First Approval:
None
UNII:
V94JSH9V48
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SARCOSINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Schizophrenia
Unknown
SARCOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Z711V88R5F
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
-0.71
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BIMIRALISIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Glioblastoma; Lymphoma; Lymphoma, Non-Hodgkin
Unknown
BIMIRALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
6Z3QHB00LB
Molecule Type:
Small molecule
Molecular Formula:
C17H20F3N7O2
Molecular Weight:
411.39
AlogP:
1.21
PSA:
102.52
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CAVATAK
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CAVATAK
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEZAKINUMAB
2
Antibody
Investigational
Unknown
Unknown
Psoriasis; Arthritis, Rheumatoid; Dermatitis, Atopic
Interleukin-22 inhibitor
FEZAKINUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
0S77U25XZ3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RINFABATE
2
Unknown
Investigational
Unknown
Unknown
Noonan Syndrome; Retinopathy of Prematurity
Unknown
RINFABATE
×
Maximum Phase:
2
First Approval:
None
UNII:
KU1MBT4JJB
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARPERITIDE
2
Protein
Investigational
Unknown
Unknown
Unknown
Atrial natriuretic peptide receptor agonist
CARPERITIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
GZ8FA500J0
Molecule Type:
Protein
Molecular Formula:
C127H203N45O39S3
Molecular Weight:
3080.5
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DROZITUMAB
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Chondrosarcoma; Lymphoma, Non-Hodgkin
Tumor necrosis factor receptor superfamily member 10B agonist
DROZITUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
SQ67484MA7
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLETIKUMAB
2
Antibody
Investigational
Unknown
Unknown
Psoriasis; Arthritis, Rheumatoid; Inflammation
Interleukin-20 inhibitor
FLETIKUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
82WG3POL9W
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOTROMBOPAG
2
Small molecule
Investigational
Unknown
Unknown
Purpura, Thrombocytopenic, Idiopathic
Unknown
TOTROMBOPAG
×
Maximum Phase:
2
First Approval:
None
UNII:
83D6475CAW
Molecule Type:
Small molecule
Molecular Formula:
C25H22N8O2
Molecular Weight:
466.51
AlogP:
4.05
PSA:
131.75
HBD:
3.0
HBA:
#RotB:
5.0
Source:
PRASINEZUMAB
2
Antibody
Investigational
Unknown
Unknown
Parkinson Disease
Alpha-synuclein binding agent
PRASINEZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
P3Z0Z3P1ZI
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PAT
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AROPLATIN
2
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms; Colorectal Neoplasms
Unknown
AROPLATIN
×
Maximum Phase:
2
First Approval:
None
UNII:
J7M4Z2D183
Molecule Type:
Small molecule
Molecular Formula:
C26H52N2O4Pt
Molecular Weight:
651.79
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
IMVANEX
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IMVANEX
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NECATOR AMERICANUS
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NECATOR AMERICANUS
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOTOFISOPAM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LEVOTOFISOPAM
×
Maximum Phase:
2
First Approval:
None
UNII:
11ZYL7QK34
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O4
Molecular Weight:
382.46
AlogP:
4.44
PSA:
61.64
HBD:
0.0
HBA:
#RotB:
6.0
Source:
LULIZUMAB PEGOL
2
Antibody
Investigational
Unknown
Unknown
Unknown
T-cell-specific surface glycoprotein CD28 antagonist
LULIZUMAB PEGOL
×
Maximum Phase:
2
First Approval:
None
UNII:
LCT264LTYE
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEUTIVACAFTOR
2
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DEUTIVACAFTOR
×
Maximum Phase:
2
First Approval:
None
UNII:
SHA6U5FJZL
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O3
Molecular Weight:
401.55
AlogP:
5.08
PSA:
82.19
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FLUOROMISONIDAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Esophageal Neoplasms
Unknown
FLUOROMISONIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
082285VIDF
Molecule Type:
Small molecule
Molecular Formula:
C6H8FN3O3
Molecular Weight:
189.15
AlogP:
0.12
PSA:
81.19
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MILATAXEL
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Mesothelioma; Rectal Neoplasms
Unknown
MILATAXEL
×
Maximum Phase:
2
First Approval:
None
UNII:
J41Q4S20GS
Molecule Type:
Small molecule
Molecular Formula:
C45H56O16
Molecular Weight:
852.93
AlogP:
4.06
PSA:
231.63
HBD:
3.0
HBA:
#RotB:
11.0
Source:
ADIPIPLON
2
Small molecule
Investigational
Unknown
Unknown
Sleep Initiation and Maintenance Disorders
GABA-A receptor; anion channel partial agonist
ADIPIPLON
×
Maximum Phase:
2
First Approval:
None
UNII:
OPL214POJ1
Molecule Type:
Small molecule
Molecular Formula:
C18H18FN7
Molecular Weight:
351.39
AlogP:
2.83
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
5.0
Source:
2,4-DINITROPHENOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
2,4-DINITROPHENOL
×
Maximum Phase:
2
First Approval:
None
UNII:
Q13SKS21MN
Molecule Type:
Small molecule
Molecular Formula:
C6H4N2O5
Molecular Weight:
184.11
AlogP:
1.21
PSA:
106.51
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BALSTILIMAB
2
Antibody
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Neoplasms; Hemangiosarcoma; Sarcoma; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms
Programmed cell death protein 1 antagonist
BALSTILIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
1Q2QT5M7EO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LIFILEUCEL
2
Cell
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Melanoma; Uterine Cervical Neoplasms
Unknown
LIFILEUCEL
×
Maximum Phase:
2
First Approval:
None
UNII:
R0835E18NH
Molecule Type:
Cell
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VONLEROLIZUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Urinary Bladder Neoplasms
Unknown
VONLEROLIZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
C78148TF1D
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
136
137
138
139
140
141
142
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA